AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers.


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
10 2019
Historique:
received: 10 01 2019
revised: 29 05 2019
accepted: 08 07 2019
pubmed: 14 7 2019
medline: 17 7 2020
entrez: 14 7 2019
Statut: ppublish

Résumé

The architectural chromatin protein HMGA1 and the transcription factor Fra-1 are both overexpressed in aggressive triple-negative breast cancers (TNBC), where they both favor epithelial-to-mesenchymal transition, invasion, and metastasis. We therefore explored the possibility that Fra-1 might be involved in enhanced transcription of the

Identifiants

pubmed: 31300541
pii: 1541-7786.MCR-19-0036
doi: 10.1158/1541-7786.MCR-19-0036
doi:

Substances chimiques

HMGA1 protein, human 0
Transcription Factor AP-1 0
HMGA1a Protein 124544-67-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1999-2014

Informations de copyright

©2019 American Association for Cancer Research.

Auteurs

Claire Tolza (C)

Equipe Labellisée par la Ligue contre le Cancer, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Fabienne Bejjani (F)

Equipe Labellisée par la Ligue contre le Cancer, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Lebanese University of Beirut, Rafic Hariri Campus, Hadath, Beirut, Lebanon. M. Piechaczyk and I. Jariel-Encontre are the cosenior authors of this article.

Emilie Evanno (E)

Equipe Labellisée par la Ligue contre le Cancer, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Samantha Mahfoud (S)

Equipe Labellisée par la Ligue contre le Cancer, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.
Lebanese University of Beirut, Rafic Hariri Campus, Hadath, Beirut, Lebanon. M. Piechaczyk and I. Jariel-Encontre are the cosenior authors of this article.

Gabriel Moquet-Torcy (G)

Equipe Labellisée par la Ligue contre le Cancer, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Thierry Gostan (T)

Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Muhammad Ahmad Maqbool (MA)

Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Olivier Kirsh (O)

Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Marc Piechaczyk (M)

Equipe Labellisée par la Ligue contre le Cancer, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Isabelle Jariel-Encontre (I)

Equipe Labellisée par la Ligue contre le Cancer, Montpellier, France. isabelle.jariel@igmm.cnrs.fr.
Institut de Génétique Moléculaire de Montpellier, University of Montpellier, CNRS, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH